Study Group: Generic Pharmaceuticals Economic Experts (Germany)

Council Members in this Study Group: 58

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Jan Hacker, Managing Partner, Oberender & PartnerJan Hacker

Managing Partner
Oberender & Partner
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Jan Hacker is the Managing Partner and Co-founder of Oberender & Partner, a leading Healthcare Consulting Company catering to the healthcare services, medical technology, pharmaceutical industry and health insurance companies as well as other institutions...

David Sykes, Principal, PRMA Consulting Ltd.David Sykes

Principal
PRMA Consulting Ltd.
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

David Sykes is the Founding Partner and Principal of PRMA Consulting, United Kingdom. He is an expert in pricing, reimbursement, and health outcomes within pharmaceutical and medical device sectors. Mr. Sykes has over 14 years of blue chip experience...

1 news post(s)
John Ansell, Director, John Ansell ConsultancyJohn Ansell

Director
John Ansell Consultancy
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

John Ansell has been the Director of John Ansell Consultancy, a pharmaceutical consulting firm in Thame, UK, since 1990. Mr. Ansell has advised over 130 pharma, biotech and companies providing pharmaceutical services. He focuses on international marketing...

23 news post(s)
Patrick Da-Cruz

Project Manager
Oberender & Partner
What is a GLG Scholar?|GLG Scholar denotes Council Members with a CouncilRank(SM) in the top 20%.

Patrick Da-Cruz is a Project Manager at Oberender and Partner, part of Economedic AG, Germany. Previously, Mr. Da-Cruz has worked in different positions at Ratiopharm, including corporate development and corporate purchasing. He has worked for over four...

Dilip Shah, Chief Executive Officer, Vision Consulting GroupDilip Shah

Chief Executive Officer
Vision Consulting Group
What is a GLG Scholar?|GLG Scholar denotes Council Members with a CouncilRank(SM) in the top 20%.

Dilip Shah is Chief Executive Officer of Vision Consulting Group, a strategic planning firm in India. Mr. Shah is an independent Director on the Board of Fresenius Kabi Oncology Limited and Anuh Pharma Limited. He has 44 years of varied experience in...

1 event(s)
Join this Study Group

Members in this Study Group include these company types:

  • Consultancy, Pharma-Focused
  • Pharmacy or Drug Store, Independent/Local
  • Pharmaceuticals Manufacturer
  • Academic Institution*
  • Individual/Small Consultancy
  • Consultancy, Healthcare-Focused
  • Drug Distributor, General or Full-Spectrum
  • Strategic Management
  • Academic Medical Center/Hospital or Clinic
  • Contract Research Organization, Independent/Small
  • Law Firm (general practice/large)

Members in this Study Group often have these job titles:

  • Director
  • Owner
  • Consultant
  • Chief Executive Officer
  • Principal
  • President
  • Operations Executive
  • Project Manager

Related Study Groups

Study Group Name No. Members
Experts on Generic Pharmaceuticals: Pharmacists 114
Anesthesiologists (EU) 272
Medical Device Experts 513
Generic Pharmaceuticals Regulation Experts: Healthcare Consultants 57
Medical Tourism Experts 350
Healthcare Experts: Lawyers (EU) 134
Managed Care Experts 733
Pharmaceutical and Biotechnology Experts: Lawyers (EU) 82

GLG Live Meetings with this Study Group's Leading Experts (?)

Upcoming Seminars

Leading Experts in Generic Pharmaceuticals Economic Experts (Germany) Study Group have not participated in any upcoming seminars.

View All GLG Live Meetings in Healthcare

Webcast: Indian Generics Market – Challenges and Opportunities to Come (2:30PM IST)

1/19/2011